119
Participants
Start Date
January 7, 2020
Primary Completion Date
December 5, 2022
Study Completion Date
December 5, 2022
branebrutinib
Specified dose on specified days
abatacept
Specified dose on specified days
branebrutinib placebo
Specified dose on specified days
Local Institution - 0069, Leuven
Local Institution - 0064, Ghent
Local Institution, New York
Local Institution - 0038, Berlin
Local Institution, Manhasset
Local Institution - 0070, Marseille
Local Institution - 0028, A Coru
Local Institution - 0010, Duncansville
Local Institution - 0006, Salisbury
Local Institution - 0008, Charlotte
Local Institution - 0025, Málaga
Local Institution - 0045, Orangeburg
Local Institution - 0021, Summerville
Local Institution - 0075, Brest
Local Institution - 0009, Lawrenceville
Local Institution, Jacksonville
Local Institution - 0062, DeBary
Local Institution - 0035, Hialeah
Local Institution - 0029, Plantation
Local Institution, Brandon
Local Institution - 0067, Montpellier
Local Institution - 0001, Memphis
Local Institution - 0079, Jackson
Local Institution - 0018, Seville
Local Institution - 0060, Guadalajara
Local Institution - 0074, Herne
Local Institution - 0042, Guadalajara
Local Institution - 0113, Zapopan
Local Institution - 0061, Valencia
Local Institution, Evansville
Local Institution - 0041, Ann Arbor
Local Institution - 0082, Grand Blanc
Local Institution - 0037, Cologne
Local Institution, Minot
Local Institution - 0014, Skokie
Local Institution - 0102, Cuernavaca
Local Institution - 0096, St Louis
Local Institution - 0040, St Louis
Local Institution - 0056, Lincoln
Local Institution - 0005, Monroe
Local Institution - 0030, Plano
Local Institution - 0016, Mesquite
Local Institution, Dallas
Local Institution - 0092, Colleyville
Local Institution, Waco
Local Institution - 0063, Houston
Local Institution - 0114, San Luis Potosí City
Local Institution - 0050, San Luis Potosí City
Local Institution - 0031, San Antonio
Local Institution - 0059, San Luis Potosí City
Local Institution - 0049, Freiburg im Breisgau
Local Institution - 0022, Oklahoma City
Local Institution - 0051, München
Local Institution - 0019, Phoenix
Local Institution - 0007, Las Vegas
Local Institution - 0024, Encino
Local Institution - 0002, Covina
Local Institution - 0032, Upland
Local Institution - 0034, San Diego
Local Institution - 0104, Mérida
Local Institution - 0083, Spokane
Local Institution - 0023, Oklahoma City
Local Institution - 0065, Ciudad Autonoma de Buenos Aires
Local Institution - 0047, San Miguel de Tucum
Local Institution - 0066, San Juan
Local Institution - 0004, Groningen
Local Institution - 0094, Bialystok
Local Institution - 0089, Bydgoszcz
Local Institution - 0072, Bydgoszcz
Local Institution - 0012, Elblag
Local Institution - 0073, Elblag
Local Institution - 0011, Poznan
Local Institution - 0091, Torun
Local Institution - 0017, Warsaw
Local Institution - 0033, Warsaw
Local Institution - 0101, Warsaw
Local Institution - 0026, Warsaw
Local Institution - 0036, Barcelona
Local Institution - 0076, Leeds
Local Institution - 0058, London
Local Institution - 0052, Southampton
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY